Hair miR-29a Levels Are Decreased in Patients with Scleroderma
October 2013
in “
Experimental dermatology
”
TLDR Scleroderma patients have lower hair miR-29a levels.
The study found that hair miR-29a levels were significantly lower in scleroderma patients compared to control subjects and dermatomyositis patients. This suggests that hair miR-29a could serve as an independent biomarker for scleroderma, as there was no strong correlation between miR-29a levels in hair, skin, and serum. Additionally, scleroderma patients with decreased miR-29a levels had a higher prevalence of phalangeal contracture. The study concluded that hair-derived miRNAs might be more useful for diagnosing chronic or genetic diseases like scleroderma rather than acute diseases. However, larger-scale studies are needed to confirm these findings.